About Monarch Bioimplants
Monarch Bioimplants is a company based in Root (Switzerland) founded in 2016 by Thomas Freier.. Monarch Bioimplants has raised $24.93 million across 2 funding rounds from investors including FastTrack Ventures and Global Emerging Markets. Monarch Bioimplants operates in a competitive market with competitors including Avation, BioCircuit, Epineuron, Tulavi Nerve Therapeutics and Micro Leads, among others.
- Headquarter Root, Switzerland
- Founders Thomas Freier
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$24.93 M (USD)
in 2 rounds
-
Latest Funding Round
$23.41 M (USD), Series B
Sep 28, 2020
-
Investors
FastTrack Ventures
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Monarch Bioimplants
Monarch Bioimplants has successfully raised a total of $24.93M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $23.41 million completed in September 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $23.4M
-
First Round
First Round
(24 Jul 2017)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2020 | Amount | Series B - Monarch Bioimplants | Valuation | Global Emerging Markets |
|
| Jul, 2017 | Amount | Seed - Monarch Bioimplants | Valuation | FastTrack Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Monarch Bioimplants
Monarch Bioimplants has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include FastTrack Ventures and Global Emerging Markets. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by this private equity firm.
|
Founded Year | Domain | Location | |
|
Investments in tech startups are managed by FastTrack Ventures.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Monarch Bioimplants
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Monarch Bioimplants
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Monarch Bioimplants Comparisons
Competitors of Monarch Bioimplants
Monarch Bioimplants operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avation, BioCircuit, Epineuron, Tulavi Nerve Therapeutics and Micro Leads, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Wearable tibial nerve stimulation device treats overactive bladder symptoms.
|
|
| domain | founded_year | HQ Location |
Non-invasive electrophysiology devices are developed to monitor peripheral nerves.
|
|
| domain | founded_year | HQ Location |
Medical devices for peripheral nerve injury treatment are provided.
|
|
| domain | founded_year | HQ Location |
Therapeutic devices for neurally mediated diseases are developed.
|
|
| domain | founded_year | HQ Location |
Micro-cuff electrodes and wireless pulse generators for neuromodulation are developed.
|
|
| domain | founded_year | HQ Location |
Provides advanced laser therapy solutions for healthcare applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Monarch Bioimplants
When was Monarch Bioimplants founded?
Monarch Bioimplants was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Where is Monarch Bioimplants located?
Monarch Bioimplants is headquartered in Root, Switzerland. It is registered at Root, Lucerne, Switzerland.
Is Monarch Bioimplants a funded company?
Monarch Bioimplants is a funded company, having raised a total of $24.93M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.52M, raised on Jul 24, 2017.
What does Monarch Bioimplants do?
Developer of bioimplant for peripheral nerve repair. The company has a NeuroShield device that provides non-constricting protection for the nervous system. It is made of naturally occurring Chitosan which shields nerves from further damage and promotes faster regrowth.
Who are the top competitors of Monarch Bioimplants?
Monarch Bioimplants's top competitors include Avation, Tulavi Nerve Therapeutics and Epineuron.
Who are Monarch Bioimplants's investors?
Monarch Bioimplants has 2 investors. Key investors include FastTrack Ventures, and Global Emerging Markets.